Pathomechanisms of neurodegeneration in glutaryl‐CoA dehydrogenase deficiency
- 1 December 2003
- journal article
- review article
- Published by Wiley in Annals of Neurology
- Vol. 55 (1), 7-12
- https://doi.org/10.1002/ana.10784
Abstract
Glutaryl‐CoA dehydrogenase deficiency is an inherited organic aciduria with predominantly neurological presentation. Biochemically, it is characterized by an accumulation and enhanced urinary excretion of two key organic acids, glutaric acid and 3‐hydroxyglutaric acid. If untreated, acute striatal degeneration is often precipitated by febrile illnesses during a vulnerable period of brain development in infancy or early childhood, resulting in a dystonic dyskinetic movement disorder. The mechanism underlying these acute encephalopathic crises has been partially elucidated using in vitro and in vivo models. 3‐Hydroxyglutaric and glutaric acids share structural similarities with the main excitatory amino acid glutamate and are considered to play an important role in the pathophysiology of this disease. 3‐Hydroxyglutaric acid induces excitotoxic cell damage specifically via activation of N‐methyl‐D‐aspartate receptors. Furthermore, glutaric and 3‐hydroxyglutaric acids indirectly modulate glutamatergic and GABAergic neurotransmission, resulting in an imbalance of excitatory and inhibitory neurotransmission. It also has been suggested that secondary amplification loops potentiate the neurotoxic properties of these organic acids. Probable mechanisms for this effect include cytokine‐stimulated nitric oxide production, a decrease in energy metabolism, and reduction of cellular creatine phosphate levels. Finally, maturation‐dependent changes in the expression of neuronal glutamate receptors may affect the vulnerability to 3‐hydroxyglutaric and glutaric acid toxicity.Keywords
Funding Information
- German Research Community (KO 2010/1-1, KO 2010/2-1)
This publication has 59 references indexed in Scilit:
- Chronic treatment with glutaric acid induces partial tolerance to excitotoxicity in neuronal cultures from chick embryo telencephalonsJournal of Neuroscience Research, 2002
- Characterization of Agonist‐Induced Down‐Regulation of NMDA Receptors in Cerebellar Granule Cell CulturesJournal of Neurochemistry, 1996
- Cloning of glutaryl-CoA dehydrogenase cDNA, and expression of wild type and mutant enzymes in Escherichia coliHuman Molecular Genetics, 1995
- A G-to-T transversion at the +5 position of intron 1 in the glutaryl CoA dehydrogenase gene is associated with the island Lake variant of glutaric acidemia type IHuman Molecular Genetics, 1995
- Macrocephaly: an important indication for organic acid analysisJournal of Inherited Metabolic Disease, 1991
- Phenotypic variability in glutaric aciduria type I: Report of fourteen cases in five Canadian Indian kindredsThe Journal of Pediatrics, 1991
- Megalencephaly in the neonatal period as the initial manifestation of glutaric aciduria type IThe Journal of Pediatrics, 1989
- Glutaric aciduria: Biochemical and morphologic considerationsThe Journal of Pediatrics, 1977
- Glutaric aciduria; A “new” disorder of amino acid metabolismBiochemical Medicine, 1975
- Brain Damage in Infant Mice following Oral Intake of Glutamate, Aspartate or CysteineNature, 1970